Product Information
DOXEPIN HCL 3 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.3644 per EA under NDC 51672424602. Its NADAC has been published 43 times since Oct 29, 2025.
FDA first approved this application on Aug 6, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672424602
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA219058FDA Approved
8/6/2025
TE Code
AB
On Market Since
8/7/2025
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 3 MG TABLET has been published 43 times since Oct 29, 2025, and over the history we have for it it has declined 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3644 per EA |
|---|---|
| All-time high | $2.1099 (Nov 12, 2025) |
| All-time low | $1.3271 (Jul 22, 2026) |
| 52-week high | $2.1099 |
| 52-week low | $1.3271 |
| Median price | $1.5861 |
| Average price | $1.6762 |
| Largest weekly change | -16.0% (Jan 21, 2026) |
| Weeks tracked | 43 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $1.3644 per EA (NDC 51672424602), effective Aug 19, 2026.
How has the price of DOXEPIN HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 35.3%. It has been tracked across 43 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?
Since Oct 29, 2025, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $1.3271 (Jul 22, 2026) to a high of $2.1099 (Nov 12, 2025), with a median of $1.5861 per EA.
Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXEPIN HCL 3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXEPIN HCL 3 MG TABLET?
DOXEPIN HCL 3 MG TABLET (NDC 51672424602) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.